---
title: "Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295190953.md"
description: "In Tokyo, Japan and Cambridge, UK, on 7 August 2026, Nxera Pharma, identified as \"the Company\" or \"Nxera\" with the stock symbol TSE: 4565, has issued an update on its operational endeavors and disclosed the consolidated outcomes for the second quarter concluding on 30 June 2026. Further details and the complete report are accessible via the provided link."
datetime: "2026-08-07T06:32:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295190953.md)
  - [en](https://longbridge.com/en/news/295190953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295190953.md)
generator: "portal-rs"
---

# Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026

In Tokyo, Japan and Cambridge, UK, on 7 August 2026, Nxera Pharma, identified as "the Company" or "Nxera" with the stock symbol TSE: 4565, has issued an update on its operational endeavors and disclosed the consolidated outcomes for the second quarter concluding on 30 June 2026. Further details and the complete report are accessible via the provided link.

### Related Stocks

- [4565.JP](https://longbridge.com/en/quote/4565.JP.md)

## Related News & Research

- [Cambridge Nutritional Sciences publishes 2026 annual report](https://longbridge.com/en/news/298269112.md)
- [Ecosuntek adds Q3 KPI update to 2026 corporate events calendar](https://longbridge.com/en/news/298712114.md)
- [TIP files H1 2026 half-year consolidated financial report as of June 30, 2026](https://longbridge.com/en/news/298760211.md)
- [Acteos delays H1 2026 results release to Oct. 28](https://longbridge.com/en/news/298618428.md)
- [HPS/PayMedix Named a 2026 Best and Brightest Company to Work For](https://longbridge.com/en/news/298358823.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**